Synthetic Cannabinoid Abuse and a Rare Alpha-1-Antitrypsin Mutant Causing Acute Fulminant Hepatitis: A Case Report and Review of the Literature
Synthetic cannabinoids (SCs) abuse is on the rise because they are easily obtained over the counter; they are potent psychoactive compounds and routine drug testing does not detect them. As their abuse is on the rise, so are their detrimental side effects; however, the occurrence of acute hepatitis...
Saved in:
Main Authors: | Kurt J. Knowles, Eric X. Wei, Abhishek Seth, John Bienvenu, James Morris, Kenneth Manas, Paul Jordan, Moheb Boktor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Hepatology |
Online Access: | http://dx.doi.org/10.1155/2017/9627452 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01) -
Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency
by: A. Vianello, et al.
Published: (2025-01-01) -
Basilar Predominant Emphysema: Thinking beyond Alpha-1-Antitrypsin Deficiency
by: Ho-Man Yeung, et al.
Published: (2022-01-01) -
The Inhibitory Effects of Alpha 1 Antitrypsin on Endosomal TLR Signaling Pathways
by: Ahmed S. Elshikha, et al.
Published: (2025-01-01) -
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
by: Jose Orsini, et al.
Published: (2015-01-01)